“Future Trends 2016 Workshop Study” conducted by Novartis and Medipol REMER was hosted by Medipol University. The program, held at Kavacık Güney Campus, was attended by academicians and public-sector representatives, including the Director of REMER, Prof. Dr.  Gürkan Öztürk. The place of Turkey in the pharmaceutical industry value chain, the current situation and 2023 roadmap topics were discussed. During the two-day sessions, investment priorities of global pharmaceutical companies, 2023 vision of the state pharmaceutical industry, pharmaceutical R & D investments and public-industry-academia cooperation were discussed.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: